Copaxone (Glatiramer acetate) is currently the biggest selling MS drug, which is a $4.2 billion blockbuster. Although invented in the 1970s it is amazing that it is only now that some of the patents are expiring and many companies are in hunt waiting to get a slice of the pie. It appears the legal hurdles impeding the launch of a generic version of multiple sclerosis (MS) drug Copaxone have been cleared by the US Supreme Court....let the price battle begin or is that in my dreams?....Or will another cartel emerge?
Though two generics teams- Novartis/Sandoz & Momenta Pharmaceuticals, and Mylan & Natco Pharma are now free to move forward, they'll have to fork over infringement damages if Teva ultimately prevails in court.
Labels: copaxone, Glaterimer Acetate